Annual Reports

Annual Reports 2012

Download Entire File

Coverpage	PDF 0.1MB 2P
Contents	PDF 0.1MB 1P
Integrated Annual Report Editorial Policy	PDF 0.1MB 1P
Takeda Snapshot Innovation Culure Growth	PDF 0.6MB 6P
Financial and Non-Financial Highlights	PDF 0.1MB 2P
Message from Yasuchika Hasegawa, President & CEO	PDF 0.1MB 7P
Corporate Philosophy	PDF 0.1MB 1P
Creating Corporate Value through the Pharmaceutical Business R&D Message from Tadataka Yamada, M.D., Director and CMSO	PDF 0.3MB 8P
R&D Pipeline	PDF 0.1MB 3P
Message from Deborah Dunsire, M.D., Director and Millennium President & CEO	PDF 0.1MB 1P
In-Licensing and Alliance Activities	PDF 0.1MB 1P
CMC Center / Intellectual Property	PDF 0.1MB 1P
Production and Supply System	PDF 0.1MB 1P
Quality Assurance System	PDF 0.1MB 1P
Marketing - Core Products	PDF 0.1MB 2P
Message from Frank Morich, M.D., Ph.D., Director and CCO	PDF 0.1MB 1P
Close up Pharmaceutical Market and Industry Trends	PDF 0.4MB 1P
Performance Overview by Market	PDF 0.2MB 6P
Message from Masato Iwasaki, Director and Senior Vice President, Pharmaceutical Marketing Div	PDF 0.1MB 1P
Japanese Market	PDF 0.1MB 3P
Creating Corporate Value through CSR Takeda's CSR Activities	PDF 0.2MB 8P
Feature: Support for Areas Affected by the Great East Japan Earthquake	PDF 0.1MB 2P
Organizational Governance	PDF 0.1MB 2P
Human Rights	PDF 0.1MB 2P
Labor Practices	PDF 0.1MB 2P
The Environment	PDF 0.1MB 2P
Fair Operating Practices	PDF 0.1MB 2P
Consumer Issues	PDF 0.1MB 2P
Community Involvement and Development	PDF 0.1MB 2P
Management Organization Message from Toyoji Yoshida, Managing Director and Internal Control and Special Missions assigned by President	PDF 0.1MB 1P
Corporate Governance	PDF 0.1MB 5P
Board of Directors, Auditors and Corporate Officers	PDF 0.1MB 2P
Takeda's History	PDF 0.1MB 2P
Major Subsidiaries and Affiliates	PDF 2.6MB 2P
Financial Section	PDF 0.2MB 41P
Independent Auditor's Report	PDF 0.1MB 1P
Corporate Information	PDF 0.1MB 1P
Key Social Responsibility Indices	PDF 0.1MB 1P

2012 CSR Data Book

Download Entire File

PDF 3.4MB 130P

Download each item

Coverpage	PDF 0.1MB 1P
Contents	PDF 0.1MB 1P
Editorial Policy	PDF 0.1MB 1P
Takeda's Philosophy and Approach on Stakeholder Engagement Takeda's CSR Activities	PDF 0.1MB 1P
Basic Policy on CSR	PDF 0.1MB 1P
United Nations Global Compact	PDF 0.1MB 1P
ISO 26000 Value Chain Management	PDF 0.1MB 1P
IIRC	PDF 0.1MB 1P
AA1000 Our Stakeholders	PDF 0.1MB 1P
CSR Activity Targets and Results	PDF 0.1MB 2P
Feature: Support for Areas Affected by the Great East Japan Earthquake Organizational Governance	PDF 0.1MB 2P
CSR Management Due Diligence Stakeholder Engagement	PDF 0.1MB 2P
Message Toyoji Yoshida, Managing Director and Internal Control and Special Missions assigned by President	PDF 0.1MB 1P
Corporate Governance	PDF 0.1MB 2P
Compliance	PDF 0.1MB 1P
Crisis Management Disclosure of Information to Stakeholders Human Rights	PDF 0.1MB 2P
Human Rights Issues	PDF 0.1MB 2P
Initiatives for Human Rights Issues Labor Practices	PDF 0.1MB 2P
Global Human Resources Policy Developing a Global Talent Base	PDF 0.1MB 2P
Promoting Diversity	PDF 0.1MB 2P
Work-Life Balance Employment of People with Disabilities Health and Safety of Employees Relations with Workers Unions The Environment	PDF 0.1MB 2P
Environmental Management/ Reducing Environmental Risks	PDF 0.2MB 12P
Initiatives to Deal with Climate Change	PDF 0.1MB 3P
Water Resources Conservation Initiatives	PDF 0.3MB 1P
Biodiversity Conservation Initiatives	PDF 0.1MB 2P
Waste Reduction/ Reduction in Releases of Chemical Substances	PDF 0.1MB 3P
Air, Water, and Soil Quality Protection	PDF 0.1MB 1P
Environmental Communication/Environmental Monitors/Environmental Accounting	PDF 0.1MB 2P
Environmental Impacts Associated with Takeda Group Business Activities Messages from Business Sites	PDF 0.1MB 2P
Site Data/Views of an Independent Expert Fair Operating Practices	PDF 0.1MB 2P
Toward Fair Operating Practices/ Initiatives in the Industry Anti-Corruption/Transparency Guideline	PDF 0.1MB 2P
Fair Promotion Activities/ Global CSR Purchasing/ Guidelines for Socially Responsible Purchasing/ Green Procurement	PDF 0.1MB 2P
Global Purchasing Policy/Employee Compliance Program	PDF 0.1MB 2P
Intellectual Property Consumer Issues	PDF 0.1MB 2P
Anti-Counterfeit Measures Strengthening Value Chain Management/ Supplying Information	PDF 0.1MB 2P
Quality Assurance System	PDF 0.1MB 4P
Production and Supply System Community Involvement and Development	PDF 0.1MB 2P
Approach to Community Involvement and Development	PDF 0.1MB 2P
Partnership with NGOs and NPOs/Corporate Foundations Healthcare Support for Developing Countries	PDF 0.1MB 2P
Initiatives at Takeda Group Companies	PDF 1.6MB 36P
Takeda's History	PDF 0.1MB 2P
Corporate Information	PDF 0.1MB 1P
Key Social Responsibility Indices	PDF 0.1MB 1P
GRI Guidelines Reference Table	PDF 0.1MB 4P
Reference Table for United Nations Global Compact Advanced Level COP	PDF 0.1MB 4P
Third-Party Comment	PDF 0.1MB 2P
CSR Data Book Survey	PDF 0.1MB 1P

CSR Data Book Survey

Annual Reports 2011

Download Entire File

PDF 11.3MB 152P

Download each item

Coverpage	PDF 0.5MB 2P
Our Response to The Great East Japan Earthquake	PDF 0.1MB 2P
Contents	PDF 0.1MB 2P
Financial and Non-Financial Highlights	PDF 0.1MB 2P
Message to Stakeholders [Message and Interview] Yasuchika Hasegawa, President & CEO "The 2011-2013 Mid-Range Plan" Innovation	PDF 0.1MB 8P
Feature 1: [Dialogue] Striving for Innovation at Takeda Shigenori Ohkawa, Ph.D., Chief Scientific Officer / Deborah Dunsire, M.D., Millennium President and CEO / Tadataka Yamada, M.D., Medical and Scientific Advisor to the CEO "The Shonan Research Center" Culture	PDF 0.2MB 6P
Feature 2: Becoming a Sustainable Organization [Interview] Toyoji Yoshida, Chief Administration Officer Growth	PDF 0.1MB 4P
Feature 3: Accelerating Global Growth [Interview] Frank Morich, M.D., Ph.D., International Operations (Americas/Europe)	PDF 0.6MB 6P
Corporate Philosophy/Our Stakeholders	PDF 0.1MB 1P
Our Stakeholders	PDF 0.1MB 1P
Takeda at a Glance Industry Trends/Business Overview	PDF 0.8MB 2P
Takeda's 230-Year History Corporate Activities and Achievements in Fiscal 2010 Contribution to Society through Pharmaceutical Business	PDF 0.1MB 2P
R&D	PDF 0.4MB 3P
R&D Topics	PDF 0.1MB 2P
In-Licensing and Alliance Activities	PDF 0.1MB 2P
R&D Pipeline	PDF 0.1MB 4P
Production System	PDF 0.1MB 1P
Close-up：Vaccine Business	PDF 0.1MB 1P
Marketing [Interview] Haruhiko Hirate, International Operations (Asia)	PDF 1.0MB 11P
Consumer Healthcare Business	PDF 0.1MB 1P
Intellectual Property	PDF 0.3MB 2P
Quality Assurance System Relationship with Our Stakeholders	PDF 0.1MB 2P
Takeda's CSR Activities	PDF 0.1MB 5P
Organizational Governance	PDF 0.1MB 2P
Human Rights	PDF 0.1MB 4P
Labor Practices	PDF 0.3MB 4P
The Environment	PDF 0.1MB 6P
Fair Operating Practices	PDF 0.1MB 2P
Consumer Issues	PDF 0.1MB 2P
Community Involvement and Development Management Organization	PDF 3.6MB 6P
Corporate Governance	PDF 0.1MB 3P
Board of Directors, Auditors and Corporate Officers	PDF 0.1MB 2P
Major Subsidiaries and Affiliates Financial Section	PDF 2.2MB 2P
Review of Operations and Financial Condition	PDF 0.1MB 7P
Eleven-Year Summary of Selected Financial Data	PDF 0.1MB 2P
Consolidated Balance Sheets	PDF 0.1MB 31P
Independent Auditors' Report	PDF 0.1MB 1P
Corporate Information	PDF 0.1MB 1P
Key Social Responsibility Indices	PDF 0.1MB 1P

Annual Reports 2011

Download Entire File

PDF 6.9MB 111P

Download each item

Coverpage	PDF 0.1MB 1P
Contents	PDF 0.1MB 1P
Editorial Policy	PDF 0.1MB 1P
Our Stakeholders	PDF 0.1MB 1P
Basic Policy on CSR	PDF 0.1MB 1P
United Nations Global Compact / ISO26000	PDF 0.1MB 2P
Stakeholder-Centered Information Disclosure / Linking the GC10 Principles with ISO 26000 / ISO 26000 Core Subjects Reference Table	PDF 0.1MB 2P
CSR Activities and Targets Culture	PDF 0.1MB 2P
Feature: Becoming a Sustainable Organization [Interview] Toyoji Yoshida, Chief Administration Officer	PDF 0.1MB 4P
Takeda's 230-Year History Organizational Governance	PDF 0.1MB 2P
Corporate Governance / Crisis Management	PDF 0.1MB 2P
CSR Management / Due Diligence / Stakeholder Engagement Human Rights	PDF 0.1MB 2P
Human Rights Issues throughout the Value Chain	PDF 0.1MB 2P
Initiatives throughout the Value Chain / Treatment of Employees Labor Practices	PDF 0.1MB 2P
Global Human Resources Policy / Developing a Global Talent Base	PDF 0.1MB 2P
Global Employee Survey / Sharing Takeda-ism / Training System	PDF 0.1MB 2P
Work-Life Balance / Employment of People with Disabilities / Health and Safety of Employees / Relations with Workers Unions The Environment	PDF 0.1MB 2P
Environmental Management / Takeda Group Environmental Action Plan	PDF 0.1MB 3P
Environmental Protection and Accident Prevention?Policies and Performance	PDF 0.1MB 1P
Pharmaceutical Production Division Global EHS Policy and Guidelines	PDF 0.1MB 2P
Reducing Environmental Risks	PDF 0.1MB 4P
Initiatives to Deal with Climate Change / Water Resources Conservation Initiatives	PDF 0.2MB 2P
Biodiversity Conservation Initiatives	PDF 0.1MB 2P
Waste Reduction	PDF 0.1MB 2P
Reduction in Releases of Chemical Substances / Air and Water Quality Protection	PDF 0.1MB 2P
Environmental Communication/Environmental Monitors / Environmental Accounting	PDF 0.1MB 2P
Environmental Impacts Associated with Takeda Group Business Activities / Message from the Site	PDF 0.1MB 2P
Site Data/Views of an Independent Expert Fair Operating Practices	PDF 0.1MB 2P
Compliance /Toward Fair Operating Practices / Initiatives in the Industry	PDF 0.1MB 2P
Fair Promotion Activities / Anti-Corruption / Social Responsibility in the Value Chain	PDF 0.1MB 2P
Global Purchasing Policy / Employee Compliance Program / Promoting Green Procurement	PDF 0.1MB 2P
Intellectual Property Consumer Issues	PDF 0.4MB 2P
Anti-Counterfeit Measures / Supplying Information	PDF 0.1MB 2P
Quality Assurance System	PDF 0.1MB 4P
Supplying High-Quality Pharmaceutical Products / Social Responsibility as a Global Pharmaceutical Company: Vaccine Business Community Involvement and Development	PDF 0.1MB 2P
Policy for Corporate Citizenship Activities	PDF 0.1MB 2P
Partnership with NGOs and NPOs / Corporate Foundations / Support for Areas Affected by the Great East Japan Earthquake	PDF 0.1MB 2P
Healthcare Support for Developing Countries / Initiatives at Takeda Group Companies	PDF 4.9MB 26P
Corporate Information / Key Social Responsibility Indices	PDF 0.1MB 2P
GRI Guidelines Reference Table	PDF 0.1MB 4P
Reference Table for United Nations Global Compact Advanced Level COP	PDF 0.1MB 2P
Third-Party Comment	PDF 0.1MB 1P
CSR Data Book Survey	PDF 0.1MB 1P

Annual Reports 2010

Download Entire File

PDF 7.0MB 140P

Download each item

Table of Contents	PDF 0.1MB 1P
Highlights	PDF 0.1MB 2P
Message to Stakeholders 〜Message from and Interview with President & CEO〜 Introducing the 2010-2012 Mid-Range Plan Feature:Transformation into a New Takeda	PDF 0.1MB 8P
1. Innovation:At the Forefront of R&D in areas of Metabolic & Cardiovascular (CV), Oncology and Central Nervous System (CNS) diseases	PDF 0.1MB 4P
2. Growth:Global expansion plus CSR activities	PDF 1.1MB 4P
3. Culture:Biodiversity initiatives	PDF 0.1MB 2P
Corporate Philosophy	PDF 0.1MB 1P
Takeda's Stakeholders	PDF 0.1MB 1P
Takeda at a Glance: Industry Trends / Business Overview	PDF 1.1MB 2P
Takeda's History: Takeda's History / Significant Events of 2009 and 2010 Corporate Activities and Achievements in Fiscal 2009 Contribution to Society through Pharmaceutical Business	PDF 0.1MB 2P
Research and Development	PDF 0.4MB 3P
R&D Topics	PDF 0.1MB 1P
R&D Alliances	PDF 0.1MB 1P
R&D Pipeline	PDF 0.1MB 4P
Production System	PDF 0.2MB 2P
Marketing	PDF 0.6MB 9P
Consumer Healthcare Business	PDF 0.1MB 1P
Quality Assurance System	PDF 0.1MB 2P
Intellectual Property Relationship with Our Stakeholders	PDF 0.3MB 2P
Relationship with Society	PDF 0.8MB 16P
Relationship with Environment	PDF 0.9MB 8P
Relationship with Business Partners	PDF 0.1MB 4P
Relationship with Employees Management Organization	PDF 0.2MB 6P
Corporate Governance	PDF 0.1MB 3P
Board of Directors, Auditors and Corporate Officers	PDF 0.1MB 2P
Major Subsidiaries and Affiliates Financial Section	PDF 0.1MB 2P
Review of Operations and Financial Condition	PDF 0.1MB 7P
Eleven-Year Summary of Selected Financial Data	PDF 0.1MB 2P
Consolidated Balance Sheets	PDF 0.1MB 25P
Independent Auditors' Report	PDF 0.1MB 1P
Corporate Information	PDF 0.1MB 1P
Contact	PDF 0.1MB 1P

2010 CSR Data Book

Download Entire File

PDF 4.7MB 76P

Download each item

Table of Contents	PDF 0.1MB 1P
Takeda's Stakeholders / Basic Policy on CSR / CSR Promotion Framework / Specifying Materiality for CSR and Setting KPI	PDF 0.1MB 2P
Initiatives for the United Nations Global Compact / CSR Activities―Achievements and Targets	PDF 0.1MB 2P
Feature Global CSR / Biodiversity Initiatives	PDF 0.7MB 4P
Quality Assurance System	PDF 0.1MB 4P
Production System / Patient-Oriented Formulation Technology and Quality Design Relationship with Society	PDF 0.2MB 2P
Takeda's Corporate Citizenship Activities	PDF 0.3MB 2P
Feature: Supporting Children in Long-Term Treatment Activities in Japan (Stakeholder Dialogue)	PDF 0.2MB 4P
Activities in Africa and Asia	PDF 0.1MB 2P
Activities in the U.S.	PDF 0.2MB 3P
Activities in the U.S.,France,Germany,Italy and the UK	PDF 0.2MB 4P
Activities in Chine,Taiwan and the Philippines	PDF 0.1MB 3P
Activities in Thailand and Indonesia	PDF 0.1MB 2P
Corporate Foundations and Employee Volunteer Activities, etc.	PDF 0.1MB 2P
Other Activities Relationship with Environment	PDF 0.2MB 2P
Feature: Climate Change and Water Resources Conservation Initiatives	PDF 0.8MB 2P
Basic Principles on the Environment / Environment and Safety Management Structure	PDF 0.1MB 1P
Policies and Achievements / Takeda Group's Standard for Environmental Protection and Accident Prevention Work / Responsible Care Activities	PDF 0.1MB 1P
Initiatives to Reduce Environmental Risks / Environmental Protection and Accident Prevention Audit	PDF 0.1MB 2P
Accident Prevention Initiatives	PDF 0.1MB 1P
Environmental and Safety Measures at New Research Center	PDF 0.1MB 1P
Waste Reduction	PDF 0.1MB 2P
Reduction in Releases of Chemical Substances / Air, Water, and Soil Quality Protection	PDF 0.1MB 2P
Environmental Impacts Associated with Business Activities / Environmental Accounting	PDF 0.1MB 1P
Dialogue with Stakeholders	PDF 0.1MB 1P
Environmental Impact Data by Site Relationship with Business Partners	PDF 0.1MB 2P
Feature: Value Chain Management	PDF 0.1MB 2P
Basic Purchasing Policy / Committed to Sound and Fair Business Relationships / Assessment of Business Partners / Employee Compliance Program / Green Procurement Initiatives Relationship with Employees	PDF 0.1MB 2P
Feature: Promoting Diversity	PDF 0.1MB 2P
Rights of Individuals / Shared Values of Takeda-ism / Cultivating Employees in Japan, etc.	PDF 0.1MB 2P
Work-Life Balance / Employment of People with Disabilities / Mental Healthcare, etc.	PDF 0.1MB 2P
Corporate Governance	PDF 0.1MB 1P
Compliance	PDF 0.1MB 1P
Crisis Management	PDF 0.1MB 1P
Corporate Information	PDF 0.1MB 1P
GRI Guidelines Reference Table	PDF 0.1MB 4P
Third-Party Comment	PDF 0.1MB 1P
CSR Data Book Survey	PDF 0.1MB 1P

2009 Annual Report

Download Entire File

PDF 5.0MB 130P

Download each item

Table of Contents	PDF 0.1MB 1P
Highlights	PDF 0.1MB 2P
Message to Stakeholders 〜President's Message and Interview〜	PDF 0.1MB 8P
Corporate Philosophy	PDF 0.1MB 1P
Takeda's Stakeholders	PDF 0.1MB 1P
Takeda at a Glance / Industry Trends / Business Overview Feature: Launching Takeda as a World-Class Pharmaceutical Company	PDF 0.2MB 2P
1. Streamlined Governance for Global Operations	PDF 0.1MB 2P
2. An Outstanding Oncology Strategy	PDF 0.2MB 4P
3. Participating in the United Nations Global Compact Corporate Activities and Performance in Fiscal 2008 Contribution to Society through Pharmaceutical Business	PDF 0.2MB 4P
Research & Development	PDF 0.1MB 3P
R&D Pipeline	PDF 0.1MB 4P
Intellectual Property	PDF 0.1MB 2P
R&D Alliance	PDF 0.1MB 1P
Production System	PDF 0.1MB 1P
International Strategic Products (Ethical Drugs)/Consumer Healthcare Business	PDF 0.3MB 2P
Quality Assurance System	PDF 0.1MB 2P
Marketing Relationship with Our Stakeholders	PDF 0.3MB 7P
Relationship with Society	PDF 0.7MB 12P
Relationship with Environment	PDF 1.0MB 12P
Relationship with Suppliers	PDF 0.1MB 4P
Relationship with Employees Management Organization	PDF 0.3MB 7P
Corporate Governance	PDF 0.1MB 3P
Board of Directors, Auditors and Corporate Officers	PDF 0.1MB 1P
Major Subsidiaries and Affiliates Financial Section	PDF 0.1MB 2P
Review of Operations and Financial Condition	PDF 0.2MB 7P
Eleven-Year Summary of Selected Financial Data	PDF 0.1MB 2P
Consolidated Balance Sheets	PDF 0.1MB 22P
Independent Auditors' Report	PDF 0.1MB 1P
Corporate Information	PDF 0.1MB 1P

2009 CSR Data Book

Download Entire File

PDF 3.1MB 67P

Download each item

Table of Contents	PDF 0.1MB 1P
Basic Policy on CSR / CSR Promotion Framework / CSR Activities in Fiscal 2009	PDF 0.1MB 2P
Participating in the United Nations Global Compact	PDF 0.2MB 4P
Quality Assurance System Relationship with Society	PDF 0.2MB 4P
Feature: Access to Healthcare in Asia (Activities in Asia)	PDF 0.1MB 2P
Takeda's Corporate Citizenship Activities	PDF 0.1MB 2P
Activities in the U.S.	PDF 0.1MB 2P
Activities in France and Germany	PDF 0.1MB 2P
Activities in Italy and the UK	PDF 0.1MB 2P
Activities in Japan and Taiwan	PDF 0.1MB 2P
Activities in the Philippines and Thailand	PDF 0.1MB 2P
Other Activities Relationship with Environment	PDF 0.1MB 2P
Feature: Biodiversity and Water Resources Conservation Initiatives	PDF 0.6MB 2P
Feature: Initiatives to Deal with Climate Change	PDF 0.1MB 2P
Basic Principles on the Environment / Environment and Safety Management Structure	PDF 0.1MB 1P
Policies and Achievements / Takeda Group's Standard for Environmental Protection and Accident Prevention at Work / Responsible Care Activities	PDF 0.1MB 1P
Environmental Risk Reduction / Environmental Protection and Accident Prevention Audit	PDF 0.1MB 2P
Accident Prevention	PDF 0.1MB 1P
Environment and Safety Measures at New Research Center	PDF 0.1MB 1P
Waste Reduction	PDF 0.1MB 2P
Reduction in Releases of Chemical Substances / Air and Water Quality Protection	PDF 0.1MB 2P
Environmental Impacts Associated with Business Activities / Environmental Accounting	PDF 0.1MB 1P
Environmental Communications	PDF 0.1MB 1P
Environmental Impact Data by Site Relationship with Suppliers	PDF 0.1MB 2P
Feature: Supply Chain Management	PDF 0.1MB 2P
Basic Purchasing Policy / Green Procurement and CSR Procurement Initiatives Relationship with Employees	PDF 0.1MB 2P
Feature: Cultivating Talent to Lead a World-Class Pharmaceutical Company	PDF 0.1MB 2P
Rights of Individuals / Shared Values of Takeda-ism / Cultivating Employees in Japan	PDF 0.1MB 2P
Work-Life Balance / Employment of People with Disabilities / Mental Healthcare	PDF 0.1MB 2P
Employees Who Embody the Takeda-ism Ideals	PDF 0.1MB 2P
Corporate Governance	PDF 0.1MB 1P
Compliance	PDF 0.1MB 1P
Crisis Management	PDF 0.1MB 1P
Corporate Information	PDF 0.1MB 1P
GRI Guidelines Reference Table	PDF 0.1MB 4P
Third Party Opinion	PDF 0.1MB 1P

2008 Annual Report

Download Entire File

PDF 8.7MB 111P

Download each item

Table of Contents	PDF 0.4MB 1P
Highlights	PDF 1.5MB 2P
To Our Stakeholders 〜Message from the Senior Management〜	PDF 1.0MB 6P
Management Topics 1 The Restructuring of U.S. Operations 2 Strengthening Strategy in Oncology Area	PDF 1.6MB 6P
Corporate Philosophy	PDF 0.4MB 1P
Corporate Governance	PDF 1.5MB 3P
Intellectual Property	PDF 0.8MB 2P
Special Feature Business Development in Europe R&D in Europe Operations in Europe Marketing in Europe CSR in Europe Corporate Activities and Performance in Fiscal 2007 Contribution to Society through Pharmaceutical Business	PDF 1.4MB 6P
Takeda at a Glance / Industry Trends	PDF 0.5MB 1P
Research and Development	PDF 1.3MB 2P
R&D Pipeline	PDF 1.6MB 5P
Production System	PDF 0.5MB 1P
International Strategic Products (Ethical Drugs) / Consumer Healthcare Business	PDF 1.2MB 2P
Marketing Relationship with Our Stakeholders	PDF 0.9MB 4P
Relationship with Society Japan and Asia, U.S., Europe	PDF 1.3MB 7P
Relationship with Environment Special Feature: Global Warming Prevention	PDF 1.5MB 10P
Relationship with Suppliers	PDF 0.8MB 2P
Relationship with Employees Financial Section	PDF 1.3MB 4P
Review of Operations and Financial Condition	PDF 0.6MB 9P
Eleven-Year Summary of Selected Financial Data	PDF 0.4MB 2P
Consolidated Balance Sheets	PDF 0.5MB 21P
Independent Auditors' Report	PDF 0.4MB 1P
Board of Directors, Auditors and Corporate Officers	PDF 0.4MB 1P
Major Subsidiaries and Affiliates	PDF 0.4MB 2P
Corporate Information	PDF 0.4MB 1P
Contact	PDF 0.3MB 1P

2007 Annual Report

Download Entire File

PDF 4.4MB 94P

Download each item

Table of Contents	PDF 0.1MB 1P
Highlights	PDF 0.1MB 2P
To Our Stakeholders Summary of Accomplishments in Fiscal 2006 / Management Tasks for Fiscal 2007	PDF 0.3MB 6P
Corporate Philosophy/Relationship with Our Stakeholders	PDF 0.1MB 1P
Corporate Governance	PDF 0.1MB 1P
Compliance	PDF 0.1MB 1P
Risk Management	PDF 0.1MB 1P
Intellectual Property Corporate Activities and Performance of Fiscal 2006 Contribution to Society through Pharmaceutical Business	PDF 0.1MB 2P
Industry Trends	PDF 0.1MB 1P
The Special Feature in the U.S. Business Operation	PDF 0.3MB 4P
Research and Development	PDF 0.2MB 5P
Production System	PDF 0.2MB 1P
International Strategic Products ( Ethical Drugs) / Consumer Healthcare Drugs & Quasi-Drugs (Consumer Healthcare Business)	PDF 0.3MB 2P
Marketing	PDF 0.3MB 4P
Developing Superior Medicines Corresponding to Stakeholders' Aspirations Relationship with Our Stakeholders	PDF 0.1MB 1P
Relationship with Society - Japan, U.S.A., Europe and Asia	PDF 0.5MB 5P
Relationship with Environment	PDF 0.4MB 10P
Relationship with Supplier	PDF 0.1MB 2P
Relationship with Employee Financial Section	PDF 0.5MB 6P
Review of Operations and Financial Condition	PDF 0.4MB 9P
Eleven-Year Summary of Selected Financial Data	PDF 0.1MB 2P
Consolidated Financial Statements	PDF 0.1MB 14P
Independent Auditors' Report	PDF 0.1MB 1P
Board Of Directors, Auditors And Corporate Officers	PDF 0.1MB 1P
Main Subsidiaries And Affiliates	PDF 0.1MB 2P
Corporate Information	PDF 0.1MB 1P
Contact	PDF 0.1MB 1P

2012 Annual Report

2012 CSR Data Book

2011 Annual Report

2011 CSR Data Book

2010 Annual Report

2010 CSR Data Book

2009 Annual Report

2009 CSR Data Book

2008 Annual Report

2007 Annual Report